ABVC BioPharma (ABVC) Earnings Date, Estimates & Call Transcripts → Shocking $16T Elon Musk Crypto Leak (From Crypto 101 Media) (Ad) Free ABVC Stock Alerts $0.78 -0.01 (-1.27%) (As of 06/7/2024 ET) Add Compare Share Share EarningsStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesOwnershipSEC FilingsShort InterestTrendsStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesOwnershipSEC FilingsShort InterestTrends Earnings SummaryUpcoming Earnings DateAug. 12EstimatedActual EPS (May. 17) -$0.40 Missed By -$0.40 Get ABVC BioPharma Earnings AlertsEnter your email address below to receive the latest news and earnings results for ABVC and its competitors with MarketBeat's FREE daily newsletter. Skip Charts & View Estimated and Actual Earnings DataEarnings Per ShareRevenueABVC Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.ABVC Estimated and Actual Revenue by Quarter Estimated Revenue and Actual Revenue by Quarter Chart DescriptionThe chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter. Ad Porter & CompanyElon to Transform U.S. Economy? A radical, potentially game-changing technology that threatens to destroy the trillion-dollar, “green energy” grift of the elites. And yet, while it threatens their wealth and power, it could be transformational for both the U.S. economy and your wealth.One company holds a near-total monopoly on it. ABVC Earnings Date and InformationABVC BioPharma last announced its earnings data on May 17th, 2024. The reported ($0.40) earnings per share (EPS) for the quarter. ABVC BioPharma has generated ($2.25) earnings per share over the last year (($2.25) diluted earnings per share). ABVC BioPharma has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Monday, August 12th, 2024 based off prior year's report dates.Read More ABVC BioPharma Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years 10 Years Time Frame * Start Date * End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueCall Transcript 8/12/2024(Estimated)------- 5/17/2024Q1 2024-($0.40)($0.40)($0.40)--3/13/2024Q4 2023-($0.35)($0.35)($0.35)--11/15/2023Q3 2023-($0.82)($0.82)($0.82)-$0.02 million8/14/2023Q2 2023-($0.68)($0.68)($0.68)-$0.01 million5/15/2023Q1 2023($0.50)($0.60)($0.10)($0.06)-$0.13 million4/3/2023Q4 2022($1.90)($1.50)+$0.40($0.15)$0.03 million$0.59 million Get the Latest News and Ratings for ABVC and Related StocksEnter your email address below to receive the latest news and analysts' ratings for ABVC BioPharma and its competitors with MarketBeat's FREE daily newsletter. 11/14/2022Q3 2022($2.00)($1.10)+$0.90($0.11)$0.03 million$0.04 million8/15/2022Q2 2022($2.00)($0.60)+$1.40($0.06)$0.03 million$0.31 million5/16/2022Q1 2022-($2.00)($2.00)($0.20)-$0.03 million3/31/2022Q4 2021($0.40)($3.10)($2.70)($0.31)$0.19 million($0.04) million11/15/2021Q3 2021($0.40)($0.70)($0.30)($0.07)$0.14 million$0.10 million8/12/2021Q2 2021($0.40)($0.80)($0.40)($0.08)$0.11 million$0.03 million11/17/2020Q3 2020-($0.90)($0.90)($0.09)-$0.12 million8/14/2020Q2 2020-($0.50)($0.50)($0.01)-$0.23 million6/29/2020Q1 2020-($0.60)($0.60)($0.06)-$0.08 million5/15/2020Q4 2019-($0.60)($0.60)($0.06)-$0.10 million11/18/2019Q4 2019-($0.70)($0.70)($0.07)-$0.20 million8/9/2019Q3 2019-($0.30)($0.30)($0.03)-$0.19 million ABVC BioPharma Earnings - Frequently Asked Questions When is ABVC BioPharma's earnings date? ABVC BioPharma has not confirmed its next earnings publication date, but the company's estimated earnings date is Monday, August 12th, 2024 based off last year's report dates. Learn more on ABVC's earnings history. How much revenue does ABVC BioPharma generate each year? ABVC BioPharma (NASDAQ:ABVC) has a recorded annual revenue of $150,000.00. How much profit does ABVC BioPharma generate each year? ABVC BioPharma (NASDAQ:ABVC) has a recorded net income of -$10.52 million. ABVC has generated -$2.25 earnings per share over the last four quarters. More Earnings Resources from MarketBeat Related Companies: EYEN Earnings Date ACXP Earnings Date RVPH Earnings Date VYNE Earnings Date FBIO Earnings Date LPCN Earnings Date MRKR Earnings Date PMN Earnings Date XLO Earnings Date CARA Earnings Date Earnings Tools: Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country: U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Australia Earnings Reports Latest Articles: CrowdStrike's Earnings: Consolidation and AI-Driven Growth The Most Upgraded Stocks After the Q1 Earnings Season ZIM Shipping Stock Forecast, Earnings Triggers a BuyAmerican Superconductor's Earnings Surge, Future Growth ExpectedHormel: A Potential Buy Despite Post-Earnings DeclineCanopy Growth’s Earnings: Profitability Despite Industry ShiftsAbercrombie & Fitch First Quarter Earnings Surge to New Heights This page (NASDAQ:ABVC) was last updated on 6/9/2024 by MarketBeat.com Staff From Our PartnersTop 5 Tech Stocks to Buy for 2024The next evolution of technology is already upending industries worth $7 Trillion… It's already got the world'...Daily Market Alerts | SponsoredTop 5 AI Stocks to Buy for 2024The electric vehicle boom is accelerating – and fast.Market Moving Trends | SponsoredNo Strings Attached: Get 30 Days of Hedgeye’s Top Stock Picks for FreeOptimize your stock investing strategy with Hedgeye's Investing Ideas, where rigorous fundamental stock analys...Hedgeye | SponsoredMajor Elon Musk Crypto Leak RevealedReports of a leaked meeting between Elon Musk and staff at X.com could send shockwaves through the crypto mark...Crypto 101 Media | SponsoredThe Only Energy Play You Should Be Looking AtOpen AI’s Sam Altman recently helped this company raise $577 million in funding… What’s more is, It has alr...Wealthpin Pro | Sponsored"The Biggest Drug Ever" Is ComingUBS bank predicts it will become "The Biggest Drug Ever." The Wall Street Journal believes it will be "Phar...Behind the Markets | SponsoredRSVP: Charles Payne’s Cash Flow WorkshopDid you know you could "cash flow" the stocks in your portfolio? Without selling a single share of stock? ...Unstoppable Prosperity | SponsoredAI's Next Magnificent SevenThe Original Magnificent Seven Produced 16,894% Average Returns Over 20 Years.The Oxford Club | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding ABVC BioPharma, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share ABVC BioPharma With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.